Governance, scope and transition into an IP role

Employer governance, service scope, controlled drugs, remote prescribing, supervision and maintaining competence.

Pre-prescribing foundation: this module develops knowledge and judgement for formal prescribing education; it does not authorise prescribing.

• Define employer/service governance for pharmacist prescribing.
• Separate registration status from competence for a specific clinical scope.
• Plan safe expansion or change of scope.
• Recognise heightened governance for controlled drugs, high-risk and remote prescribing.
• Maintain competence through supervision, review and evidence.

Employer/service governance must define clinical scope, access to records, formulary, monitoring, supervision and escalation.

The ability to prescribe from registration does not imply immediate competence for all settings or conditions.

Expansion of scope should be deliberate, evidenced and supported.

Controlled drugs, remote prescribing and high-risk medicines need explicit service governance.

Applied scenarios

A pharmacist moves from hypertension prescribing into anticoagulation without a scope-change process.

A remote prescribing service lacks reliable access to monitoring results.

1. Define the clinical problem and whether prescribing is indicated.
2. Gather the patient-specific assessment and diagnostic information needed.
3. Check competence, professional authority and employer/service scope.
4. Compare reasonable options using current authoritative sources.
5. Agree the plan with the patient, including uncertainty and alternatives.
6. Prescribe accurately only when the decision is justified.
7. Document, monitor, review and safety-net.

Module emphasis: Ensure the service specification, records access, formulary, monitoring, supervision and escalation arrangements match the intended prescribing scope before practice begins or expands.

Scenario 1. A pharmacist moves from hypertension prescribing into anticoagulation without a scope-change process.

Reasoning prompt: For each scenario, identify the governance and scope-of-practice issue, what evidence or supervision is required, and whether prescribing should pause until records, monitoring, local authorisation or escalation arrangements are adequate.

Scenario 2. A remote prescribing service lacks reliable access to monitoring results.

Reasoning prompt: For each scenario, identify the governance and scope-of-practice issue, what evidence or supervision is required, and whether prescribing should pause until records, monitoring, local authorisation or escalation arrangements are adequate.

• A legal entitlement to prescribe means the person is competent for every medicine and condition.
• Electronic prescribing systems remove the need for clinical checking.
• If a medicine appears in a formulary or BNF, it is automatically appropriate for the patient.
• Completing an educational programme is the same as professional authorisation to prescribe.

• What clinical problem am I trying to solve, and is prescribing indicated?
• What information is missing before a safe decision can be made?
• What regulator route/annotation applies, and what separate employer/service authorisation is required?
• Which current authoritative medicine or guideline source should I check?
• What patient-specific factors change benefit, harm, dose, route or monitoring?
• What will I document, monitor, review and safety-net?
• When should I seek supervision, pharmacy advice, specialist input or urgent escalation?

Optional reflection: Without entering identifiable patient or employer information, identify one capability you would need to strengthen before prescribing independently in this area.

• Employer/service governance must define clinical scope, access to records, formulary, monitoring, supervision and escalation.
• The ability to prescribe from registration does not imply immediate competence for all settings or conditions.
• Expansion of scope should be deliberate, evidenced and supported.
• Controlled drugs, remote prescribing and high-risk medicines need explicit service governance.

Check current versions for time-sensitive decisions.

• GPHC-01 - General Pharmaceutical Council: Standards for education and training of pharmacist independent prescribersOpen official source
• GPHC-03 - General Pharmaceutical Council: Advice for newly qualified prescribing pharmacists (June 2026)Open official source
• HEIW-01 - Health Education and Improvement Wales: Standards for Competency Assurance of Independent and Supplementary Prescribers in WalesOpen official source
• LAW-02 - UK Parliament: Misuse of Drugs Regulations 2001 and amendmentsOpen official source
• LAW-03 - UK Government: Circular 009/2012 controlled-drug changesOpen official source